IRIS

Sfoglia per Rivista  RADIOTHERAPY AND ONCOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 28 a 47 di 137
Titolo Data di pubblicazione Autore(i) File
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 1-gen-2018 Meattini, I; Pasinetti, N; Meduri, B; De Rose, F; De Santis, Mc; Lancellotta, V; Rossi, F; Franco, P; Alongi, F; Saieva, C; Olmetto, E; Desideri, I; D'Angelo, E; Triggiani, L; Ricardi, U; Bastiani, P; Aristei, C; Lozza, L; Scorsetti, M; Livi, L
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document 1-gen-2020 Lievens, Yolande; Guckenberger, Matthias; Gomez, Daniel; Hoyer, Morten; Iyengar, Puneeth; Kindts, Isabelle; Méndez Romero, Alejandra; Nevens, Daan; Palma, David; Park, Catherine; Ricardi, Umberto; Scorsetti, Marta; Yu, James; Woodward, Wendy A
Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer 1-gen-2006 Guedea, F; Aguilo, F; Polo, A; Langley, S; Laing, R; Henderson, A; Aaltomaa, S; Kataja, V; Palmgren, J; Bladou, F; Salem, N; Gravis, G; Losa, A; Guazzoni, G; Nava, L
Effectiveness of an F-18-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial 1-gen-2016 de Bree, R; van der Putten, L; Van Tinteren, H; Wedman, J; Oyen, W; Janssen, Lm; van den Brekel, Mwm; Comans, Efi; Pruim, J; Takes, Rp; Hobbelink, Mgg; Olmos, Rv; van der Laan, Bfam; Boers, M; Hoekstra, Os; Leemans, Cr
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer 1-gen-2006 de Geus-Oei, Lf; Kaanders, Jham; Pop, Lam; Corstens, Fhm; Oyen, W
Efficacy and safety of re-irradiation of locally recurrent prostate cancer with FFF-VMAT 1-gen-2017 D'Agostino, Gr; Franzese, C; Di Brina, L; Tomatis, S; Iftode, C; Franceschini, D; Clerici, E; Reggiori, G; Tozzi, A; Navarria, P; Scorsetti, M
Evaluation of a radiotherapy-dedicated Monte Carlo environment in clinical VMAT plans. 1-gen-2018 Reggiori, G; Stravato, A; Paganini, L; Di Filippo, M; Fogliata, A; Palumbo, V; Mancosu, P; Tomatis, S; Scorsetti, M
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 1-gen-2007 Bossi, P; Orlandi, E; Locati, L; Bergamini, C; Liberatoscioli, C; Fallai, C; Palazzi, M; Olmi, P; Licitra, L
FLT-PET FOR DETECTION OF EARLY TREATMENT RESPONSE IN CERVICAL LYMPH NODE METASTASES OF HEAD AND NECK TUMOURS 1-gen-2010 Troost, E; Bussink, J; Oyen, W; Kaanders, J
FLT-PET IN HUMAN HEAD AND NECK CARCINOMAS: VALIDATION WITH HISTOPATHOLOGY OF SURGICAL SPECIMEN 1-gen-2008 Troost, E; Hoffmann, A; Siootweg, P; Merkx, M; van Dalen, J; van der Kogel, A; Oyen, W; Kaanders, J; Bussink, J
FLT-PET-CT FOR EARLY TREATMENT RESPONSE MONITORING IN HEAD AND NECK TUMOURS 1-gen-2010 Troost, E; Bussink, J; Hoffmann, A; Boerman, O; Oyen, W; Kaanders, J
Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes 1-gen-2022 Guaineri, A; Maddalo, M; Bastia, Mbde; Magrini, Sm; Toraci, C; Bossi, P; Paderno, A; Maroldi, R; Ravanelli, M; Piazza, C; La Mattina, S; Facheris, G; Volpi, G; Singh, N; Pastorello, E
HIGH DOSE TOMOTHERAPY TREATMENT OF LYMPH NODAL RELAPSE IN PROSTATE CANCER 1-gen-2008 Berardi, G; Alongi, F; Cozzarini, C; Landoni, C; Picchio, M; Fiorino, C; Guazzoni, G; Messa, C; Fazio, F; Di Muzio, N
High hypofractionation using beacon transponders in intermediate-risk prostate cancer: first results 1-gen-2017 Di Brina, L; D'Agostino, G; Franzese, C; Franceschini, D; Comito, T; De Rose, F; Navarria, P; Tozzi, A; Iftode, C; Ascolese, A; Clerici, E; Pasini, L; Benetti, A; Scorsetti, M
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 1-gen-2008 Cozzarini, C; Fiorino, C; Di Muzio, N; Valdagni, R; Salonia, A; Alongi, F; Broggi, S; Guazzoni, G; Montorsi, F; Rigatti, P; Calandrino, R; Fazio, F
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 1-gen-2018 Navarria, P; Pessina, F; Franzese, C; Tomatis, S; Perrino, M; Cozzi, L; Simonelli, M; Bello, L; Clerici, E; Riva, M; Santoro, A; Scorsetti, M
Hypofractionated radiotherapy for ductal carcinoma in situ using VMAT: acute toxicity and cosmesis 1-gen-2017 De Rose, F; Fogliata, A; Franceschini, D; Iftode, C; Ascolese, Am; Comito, T; Di Brina, L; Tozzi, A; Franzese, C; Clerici, E; D'Agostino, Gr; Navarria, P; Lobefalo, F; Scorsetti, M
Hypofractionated stereotactic RS for patients with brain metastases. Outcome evaluation and toxicity 1-gen-2016 Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; DE ROSE, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M
Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity 1-gen-2016 Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; De Rose, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M
HYPOFRACTIONATED TOMOTHERAPY TREATMENT (HTT) IN PROSTATE CANCER LYMPH NODAL RELAPSE DETECTED BY 11CCHOLINE PET/CT 1-gen-2011 Berardi, G; Pappalardi, B; Fiorino, C; Cozzarini, C; Guazzoni, G; Calandrino, R; Di Muzio, Ng
Mostrati risultati da 28 a 47 di 137
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile